EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia

Marcel Arnholdt iD, Laura Awakowicz, Bastian Kogelheide, Alexander Böddecker, Thomas Mussenbrock, Alexander Neugebauer, Leander Heisterberg iD, Markus Enderle, Sara Y Brucker, Peter Awakowicz, Martin Weiss iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c13697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Marcel Arnholdt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's Health, University of Tübingen, Tübingen72076, Germany. Hauptthemen laut MEDLINE: Argon, Plasma Gases, Uterine Cervical Dysplasia, Argon Plasma Coagulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Council (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cold atmospheric plasma (CAP) has emerged as a promising tool in biomedical applications, including the treatment of precancerous neoplasias. The clinical application of low-thermal argon plasma devitalization (ltAPD) using electrosurgical argon plasma coagulation (APC) probes demonstrated significant clinical efficacy in the treatment of cervical intraepithelial neoplasia (CIN) across several prospective clinical trials. Building on the previously demonstrated antineoplastic efficacy of ltAPD treatment, we investigated a prototype dielectric barrier discharge (DBD) plasma source as an alternative plasma generation principle for the treatment of larger areas under preclinical conditions. Both devices were characterized regarding their electrical properties, reactive oxygen and nitrogen species (RONS) generation, biological efficacy, and penetration depth. Electrical measurements revealed a significantly lower current and reduced energy output for the DBD compared to the clinically approved APC probe. Reactive species analysis demonstrated comparable hydrogen peroxide generation between both devices in argon atmospheres, while the APC probe generated higher levels of ·OH and NO2– in argon atmosphere. As the gas composition is defined entirely by the externally supplied mixture, the DBD allowed the working gas to be tuned systematically by adding small fractions of air (87.5% argon/12.5% air) which strongly enhanced nitrogen-species formation and biological efficacy. Implementation of nitrogen or air to the APC could likewise lead to an increase in nitrogen species. Ex vivo treatment of human cervical tissue displayed staining for the DNA damage marker γ-H2AX throughout the epithelial layer for both devices, without detectable structural tissue damage. Agarose gel experiments under controlled laboratory atmospheres revealed greater reactive species penetration depth for the APC probe, whereas the DBD prototype provided a larger treatment area. While DBD efficacy was demonstrated under defined laboratory gas conditions in a controlled chamber setup, these findings establish a first preclinical rationale for DBD as a complementary plasma geometry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArgonPlasma GasesUterine Cervical DysplasiaArgon Plasma CoagulationUterine Cervical NeoplasmsFemaleHumansReactive Nitrogen SpeciesReactive Oxygen Species

Stichwörter der Autor:innen

cervical intraepithelial neoplasia (CIN)cold atmospheric plasma (CAP)dielectric barrier discharge (DBD)gynecologic oncologylow-thermal argon plasma devitalization (ltAPD)plasma medicinereactive oxygen and nitrogen species (RONS)

Substanzen

ArgonPlasma GasesReactive Nitrogen SpeciesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Women's Health, University of Tübingen, Tübingen72076, Germany.
  • Department of Women's Health Tübingen, Eberhard Karls University Tübingen, Calwerstraße 7/6, Tübingen72076, Germany.
  • Chair of Applied Electrodynamics and Plasma Technology (AEPT), Faculty of Electrical Engineering and Information Technology, Ruhr University Bochum, Universitätsstrasse 150, Bochum44801.
  • Erbe Elektromedizin GmbH , Waldhörnlestraße 17, Tübingen72072, Germany.
  • NMI Natural and Medical Sciences Institute, University Tübingen, Reutlingen72770, Germany.

ORCID-Profile: Marcel Arnholdt, Leander Heisterberg, Martin Weiss

Förderung

  • German Research Council (DFG)

Zitieren

APA

Arnholdt, M., Awakowicz, L., Kogelheide, B., Böddecker, A., Mussenbrock, T., Neugebauer, A., Heisterberg, L., Enderle, M., Brucker, S. Y., Awakowicz, P., & Weiss, M. (2026). Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c13697

Vancouver

Arnholdt M, Awakowicz L, Kogelheide B, Böddecker A, Mussenbrock T, Neugebauer A, et al. Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c13697

BibTeX
@article{Arnholdt2026,
  author = {Arnholdt, Marcel and Awakowicz, Laura and Kogelheide, Bastian and Böddecker, Alexander and Mussenbrock, Thomas and Neugebauer, Alexander and Heisterberg, Leander and Enderle, Markus and Brucker, Sara Y and Awakowicz, Peter and Weiss, Martin},
  title = {Preclinical Characterization of Dielectric Barrier Discharge as a Complementary Plasma Technology for Low-Thermal Argon Plasma Devitalization of Cervical Intraepithelial Neoplasia},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c13697}
}
Kostenlos starten →